We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$9.64B
AUM Growth
-$2.48B
Cap. Flow
+$636M
Cap. Flow %
6.6%
Top 10 Hldgs %
42.18%
Holding
1,253
New
58
Increased
575
Reduced
265
Closed
42

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
SPG icon
Simon Property Group
SPG
+$213M
3
VTR icon
Ventas
VTR
+$180M
4
KRMA
Global X Conscious Companies ETF
KRMA
+$147M
5
STOR
STORE Capital Corporation
STOR
+$132M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$178M
2
PEB icon
Pebblebrook Hotel Trust
PEB
+$99.3M
3
EQIX icon
Equinix
EQIX
+$96.7M
4
DEI icon
Douglas Emmett
DEI
+$88.8M
5
CONE
CyrusOne Inc Common Stock
CONE
+$84.5M

Sector Composition

Rank Sector Weight
1 Real Estate 70.9%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
1051
DELISTED
Sage Therapeutics
SAGE
$8K ﹤0.01%
292
-3,431
-92% -$199K
TBPH icon
1052
Theravance Biopharma
TBPH
$873M
$8K ﹤0.01%
348
+28
+9% +$701
AKCA
1053
DELISTED
Akcea Therapeutics Inc
AKCA
$8K ﹤0.01%
530
– –
ALK icon
1054
Alaska Air
ALK
$5.11B
$7K ﹤0.01%
248
– –
BHR
1055
Braemar Hotels & Resorts
BHR
$163M
$7K ﹤0.01%
4,273
– –
INVA icon
1056
Innoviva
INVA
$1.6B
$7K ﹤0.01%
572
– –
KPTI icon
1057
Karyopharm Therapeutics
KPTI
$155M
$7K ﹤0.01%
24
– –
LGND icon
1058
Ligand Pharmaceuticals
LGND
$5.77B
$7K ﹤0.01%
147
-12
-8% -$680
RGNX icon
1059
Regenxbio
RGNX
$616M
$7K ﹤0.01%
208
– –
VCYT icon
1060
Veracyte
VCYT
$4.45B
$7K ﹤0.01%
276
– –
DRNA
1061
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7K ﹤0.01%
386
– –
LMNX
1062
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
254
– –
AKBA icon
1063
Akebia Therapeutics
AKBA
$338M
$6K ﹤0.01%
740
– –
BBWI icon
1064
Bath & Body Works
BBWI
$3.97B
$6K ﹤0.01%
599
– –
CHRS icon
1065
Coherus Oncology
CHRS
$217M
$6K ﹤0.01%
396
– –
EDIT icon
1066
Editas Medicine
EDIT
$399M
$6K ﹤0.01%
304
– –
ENTA icon
1067
Enanta Pharmaceuticals
ENTA
$362M
$6K ﹤0.01%
111
– –
HRB icon
1068
H&R Block
HRB
$5.98B
$6K ﹤0.01%
419
– –
MYGN icon
1069
Myriad Genetics
MYGN
$476M
$6K ﹤0.01%
420
– –
TWST icon
1070
Twist Bioscience
TWST
$5.32B
$6K ﹤0.01%
211
+25
+13% +$672
WNS
1071
DELISTED
WNS Holdings
WNS
$6K ﹤0.01%
150
-100
-40% -$6.41K
YMAB
1072
DELISTED
Y-mAbs Therapeutics
YMAB
$6K ﹤0.01%
224
– –
FLG
1073
Flagstar Bank National Association
FLG
$5.87B
$6K ﹤0.01%
+202
New +$6.71K
ITCI
1074
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
364
+62
+21% +$1.35K
TCDA
1075
DELISTED
Tricida, Inc. Common Stock
TCDA
$6K ﹤0.01%
280
– –
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Daiwa Securities Group held 1,253 positions worth $9.64B, down 20% from $12.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Daiwa Securities Group deployed $636M of net new capital in Q1 2020, opening 58 new positions and adding to 575 existing holdings. Its largest new stake was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.

By sector, the portfolio is most concentrated in Real Estate at 71% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Realty Income, an estimated $178M trimmed.

  • Daiwa Securities Group's largest Q1 2020 buy was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.
  • Daiwa Securities Group added most to Public Storage in Q1 2020, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2020 reduction was Realty Income, cutting an estimated $178M.
  • Daiwa Securities Group fully exited RTX Corp in Q1 2020, selling an estimated $10.1M.
  • Daiwa Securities Group's ten largest holdings make up 42% of its $9.64B portfolio in Q1 2020.
  • Daiwa Securities Group opened 58 new positions and closed 42 in Q1 2020.
  • Daiwa Securities Group's portfolio value fell 20% quarter-over-quarter to $9.64B.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.